Healthy pregnancy hub

Valproic Acid (Depakene®)

Last Update: 02 Apr 2025

Welcome to our fact sheet on Valproic Acid (Depakene®) and related medications (valproate, sodium valproate, and divalproex) during pregnancy and breastfeeding/ chestfeeding. The information given is based on recent research and may change as science progresses. This content does not replace personalized advice from your healthcare team.

The HEALTHY PREGNANCY HUB team is collaborating with MotherToBaby to share information on this topic. The original version is available here (November 2023).

Serene, our chatbot, can also answer your questions about medications during pregnancy.

Please note that this fact sheet is based on United States information and has been adapted for Canada, with a review by our Canadian experts. Minor differences may exist between the two countries. Always consult your healthcare professional for information tailored to your situation.

1. What is valproic acid?

Valproic acid is a medication that has been used to control seizures in the treatment of epilepsy, and to treat bipolar disorder and migraines. Valproic acid is sometimes also called sodium valproate or valproate sodium. Some brand names for valproic acid are Depakene®, Stavzor®, and Depacon®. A similar medication, divalproex (Depakote®), breaks down into valproic acid in the body. In Canada, a common brand name for divalproex is Epival®. In this fact sheet, the term ‘valproic acid’ includes all medications containing valproic acid, sodium valproate, valproate, or divalproex. 

In the United States, the Food and Drug Administration recommends that pregnant individuals do not take valproate sodium and related products, valproic acid and divalproex sodium to prevent migraine headaches. For epilepsy or bipolar disorder, valproic acid (and other products containing valproic acid) should only be prescribed during pregnancy if other medications are not effective in treating the condition or cannot be used for another reason. Other countries, like Canada, have similar recommendations. 

Sometimes when people find out they are pregnant, they think about changing how they take their medication, or stopping their medication altogether. However, it is important to talk with your healthcare providers before making any changes to how you take your medication. Your healthcare providers can talk with you about the benefits of treating your condition and the risks of untreated illness during pregnancy. 

2. What are the risks according to research?

I am taking valproic acid*, but I would like to stop taking it before getting pregnant. How long does the drug stay in my body?

People eliminate medications at different rates. In healthy non-pregnant adults, it takes 2-4 days, on average, for most of the valproic acid* to be gone from the body. 

What might happen if I stopped taking my valproic acid* and then had a seizure during my pregnancy? 

Having a seizure while pregnant might be harmful to the fetus. Complications depend on many things, such as the type of seizure, how long the seizure lasts, and the number of seizures that happen. Epileptic seizures might cause periods of time when the fetus is not getting enough oxygen, which could lead to problems with development. These seizures could also be life-threatening for both the pregnant individual and the fetus. A seizure could cause a pregnant individual to fall or have an accident that could injure themselves or the fetus. 

What might happen if I stopped taking my valproic acid* and then had a relapse of bipolar disorder during my pregnancy?

Pregnant individuals who have bipolar disorder and stop taking their medication during pregnancy might have a higher chance for symptoms of depression or mania that could be harmful to both the pregnant individual and the fetus. Episodes of depression or mania are very stressful for a pregnant individual. During manic or depressive episodes, the pregnant individual might have more trouble taking care of themselves and keeping themselves safe. 

I take valproic acid*. Can it make it harder for me to get pregnant? 

Some studies suggest that people on valproic acid might have a higher chance of developing polycystic ovary syndrome (PCOS), a condition associated with trouble getting pregnant. Studies have found that individuals with seizure disorders and individuals with bipolar disorder might have problems with their periods and trouble getting pregnant. This possible increase might be due to the conditions that the individual have, rather than the use of medication. 

Does taking valproic acid* increase the chance of miscarriage?

Miscarriage is common and can occur in any pregnancy for many different reasons. It is not known if valproic acid increases the chance of miscarriage. 

Does taking valproic acid* increase the chance of birth defects?

Every pregnancy starts out with a 3-5% chance of having a birth defect. This is called the background risk. Studies have found that taking valproic acid* in pregnancy is associated with a chance of having a baby with fetal valproate spectrum disorder which includes minor and major birth defects. Birth defects are typically classified as major if they need surgery to be repaired. Some of the birth defects that are more likely to happen include heart defects, cleft lip (when the lip does not form correctly and needs surgery to repair after birth), or neural tube defects (an opening in the baby’s spine or skull). Some babies exposed to valproic acid* might also have more minor birth defects like facial differences, such as a thin upper lip. The chance of a birth defect seems to be greater with higher doses of valproic acid or with taking it with another seizure medication. 

The most common neural tube defect linked to valproic acid use is spina bifida (opening in the spine). The chance of a neural tube defect when taking valproic acid is approximately 1 in 50 to 1 in 100 (1-2%). Taking extra folic acid before trying to get pregnant and in early pregnancy might help lower the chance of some birth defects in pregnancies exposed to valproic acid. Talk to your healthcare provider about how much folic acid you should take. For more information on folic acid, see our fact sheet here

Does taking valproic acid* in pregnancy increase the chance of other pregnancy-related problems?

Valproic acid* might increase the chance of low birth weight (weighing less than 5 pounds, 8 ounces [2500 grams] at birth). There have been reports of temporary low blood sugar levels (hypoglycemia) in newborns. 

Does taking valproic acid* in pregnancy affect future behavior or learning for the child?

Prenatal exposure to valproic acid* can increase the chance of problems with learning and development. Different studies have shown an increased chance of intellectual disability, developmental delay, autism spectrum disorder, other developmental disorders, attention deficit/hyperactivity disorder, attachment disorder, decreased language and memory skills, and decreased social and adaptive behavior skills. Not all studies have shown the same results. Some of the long-term problems in the exposed children might be due to how severe the seizure disorder is in the woman who is pregnant. 

What screenings or tests are available to see if my pregnancy has birth defects or other issues? 

There are ways to screen for neural tube defects in pregnancy. A blood test can be done to measure the amount of a protein called alpha fetoprotein (AFP) in the blood of the pregnant individual. Babies with spina bifida have higher levels of AFP. If the AFP is higher than usual in the blood test, more testing or screenings might be offered to you to get more information. 

An ultrasound that looks at the fetal spine can be used to screen for spina bifida. Ultrasounds can also screen for some other birth defects, such as a heart defect or cleft lip. Talk with your healthcare provider about any prenatal screenings or testing that are available to you. There are no tests available during pregnancy that can tell how much effect there could be on future behavior or learning. 

3. Breastfeeding/ chestfeeding while taking valproic acid*

The amount of valproic acid* that passes into breastmilk/ chestmilk is low and blood levels from exposed infants are low to undetectable. There is a theoretical (not proven) concern that infants exposed to valproic acid* through breastmilk/ chestmilk could develop liver toxicity, so infants should be monitored for any changes or problems. If you suspect the baby has symptoms such as jaundice (yellowing of the skin or eyes), rash, or fever, contact the child’s healthcare provider. Be sure to talk to your healthcare provider about all your breastfeeding/ chestfeeding questions. 

4. Fathers and sperm donors

If a male takes valproic acid, could it affect fertility or increase the chance of birth defects?

It is not known if valproic acid could affect a male’s fertility (ability to get a partner pregnant) or increase the chance of birth defects above the background risk. In general, exposures that sperm donors or fathers have are unlikely to increase risks to a pregnancy. For more information, please see the MotherToBaby fact sheet Paternal Exposures here. 

* In this fact sheet, the termvalproic acidalso includes medications from the same family, namely sodium valproate, valproate, and divalproex. 

Key points

  • Valproic acid (Depakene®, Epival®) is used to treat epilepsy, bipolar disorder, and migraines. It may also be prescribed under other names such as sodium valproate, valproate, or divalproex.
  • During pregnancy, valproic acid can increase the risk of birth defects such as spina bifida.
  • This medication may also raise the risk of developmental and learning disorders in the child.
  • Medical follow-up is essential if you are taking valproic acid during pregnancy.
  • Valproic acid passes into breastmilk/ chestmilk in small amounts, so monitoring is recommended to watch for any side effects in the nursing baby.
  • Always consult your healthcare team before stopping or changing your treatment.

References

Please click here to view references. 

URL copied!

Disclaimer

HEALTHY PREGNANCY HUB provides a source of information validated by health professionals; however, this information is provided for informational purposes only and should not replace professional advice. Medical standards and practices evolve as new data becomes available, so it is imperative to consult your doctor or a qualified health professional for any questions or concerns regarding your health without delay or omission. It is the responsibility of your treating physician or any other health professional, based on their independent experience and knowledge of the patient, to determine the best way to evaluate and treat you.

HEALTHY PREGNANCY HUB does not specifically recommend or endorse any test, practitioner, treatment, product, or opinion mentioned on our platform. HEALTHY PREGNANCY HUB also does not replace the individual patient assessment based on the examination by the healthcare provider of each patient and the consideration of laboratory data and other patient-specific factors.

The use of the information available on our site is at your own risk. No person involved in the creation, production, promotion, or marketing of HEALTHY PREGNANCY HUB guarantees or represents, expressly or implicitly, anything regarding the information available on the platform, which is provided “as it is”. All warranties are expressly excluded and disclaimed, including but not limited to implied warranties of merchantability or fitness for a particular purpose, as well as any warranties arising by law or otherwise in law or from trade or usage. Any statements or representations made by any other person or entity are void.

While consulting symptoms or other medical information on our platform may guide your discussions with your healthcare professional, this information should not be used to make a medical diagnosis or determine treatment. Before making changes to your supplement or medication regimen, please discuss with your medical team or contact 811 (Canada) to ensure the relevance of these changes to your individual situation.

Credits
MotherToBaby
Organization of Teratology Information Specialists (OTIS)
View source
Brigitte Martin
Centre Hospitalier Universitaire Sainte-Justine
Émy Roberge
Centre hospitalier universitaire Sainte-Justine

Associated Fact Sheets

Would you like to know more? Explore our associated Fact Sheets.

Resources

In this section, you can browse, in one place, through our various documents and tools for pregnant people, their families and healthcare professionals. You'll find vidéos, downloadable brochures, podcast episodes, and more!

Partners

Your pregnancy during COVID-19
uOttawa
University of Calgary
University of British Columbia
University of Saskatchewan
University of Manitoba
University of Alberta
Unité de soutien SSA
UDEM
Stratos
SOGC
RQRM
QTNPR
QPC
PWHR
Public Health Agency of Canada
PregMed France
SPOR
MPrint
Mitacs
Médicaments Grossesse
McGill
Médicament Québec
FRQ
Perinatal Network
CIHR
IQVIA
iPOP
Institut national de santé publique du Québec
INRS
Innovative Medicines Canada
IN-uTERO
Immerscience
Groww
Enrich
Design Develop Discover
CUSM
CIHR
CHU Sainte-Justine
Centre of Excellence on Partnership with Patients and the Public
CAN-AIM
Canadian Pharmacogenomics Network for Drug Safetry
CAMCCO
CAMCCO-L
C4T
BORN Ontario
Black Physicians of Canada
BC Children's Hospital
Alberta Health Services
MICYRN
UQAT
Dalhousie University